$PTN Boehringer Ingelheim is a massive Big Pharma based in Germany. I’m sure they have amazing production facilities and distribution channels throughout Europe and worldwide. Oh and their former (18 year) CEO Paul Fonteyne just got on the board of Amag through the Caligan escapades. Oh and Caligan started buying Amag shares right around the same time as the vyleesi FDA approval. Oh and Fonteyne was CEO when they shelved their own HSDD drug development back in 2010 or so after a regulatory rejection and licensed it to Sprout Pharmaceutical. That drug is now Addyi, vyleesi competitor which isn’t in the same league as vyleesi. Multiple coincidences. Multiple!
  • 6
6 Likes